search
Back to results

Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room (HeLP)

Primary Purpose

Hypothermia in Premature Infants

Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Polyethylene occlusive skin wrap
Sponsored by
Sunnybrook Health Sciences Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypothermia in Premature Infants focused on measuring Hypothermia, premature infants, Polyethylene occlusive wrap

Eligibility Criteria

24 Weeks - 28 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:Infants born at less than 28 weeks and who have prior to birth a firm decision to provide full resuscitative measures and intensive support.

-

Exclusion Criteria:1. Infants born with major congenital anomalies that are not covered by skin (e.g. gastroschisis, meningomyelocele) 2. Infants born with blistering skin conditions that preclude the use of occlusive wrap

-

Sites / Locations

  • Sunnybrook Health Sciences Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

1

2

Arm Description

Polyethylene occlusive skin wrap applied immediately after birth and removed after the infant has been admitted to a stable thermoneutral environment

Standard care

Outcomes

Primary Outcome Measures

Death to discharge or at six months corrected gestational age

Secondary Outcome Measures

1. Axillary temperature upon arrival in Neonatal Intensive Care Unit (NICU)
acidosis, hypotension, hypoglycaemia, seizures
4. Death and neurosensory disability measured at 18 months corrected gestational age
PDA, RDS, CLD, pneumothorax, sepsis, IVH, PVL, NEC, GI perforation, pulmonary hemorrhage, hearing, ROP

Full Information

First Posted
January 22, 2008
Last Updated
April 21, 2016
Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Canadian Institutes of Health Research (CIHR), Vermont Oxford Network, University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT00607464
Brief Title
Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room
Acronym
HeLP
Official Title
Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room
Study Type
Interventional

2. Study Status

Record Verification Date
April 2016
Overall Recruitment Status
Terminated
Study Start Date
September 2004 (undefined)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
October 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Canadian Institutes of Health Research (CIHR), Vermont Oxford Network, University of Alberta

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Does polyethylene occlusive wrap applied immediately after delivery to infants born at less than 28 weeks gestation decrease all-cause mortality measured at discharge compared with the standard of care as determined by the Neonatal Resuscitation Program guidelines (i.e. drying under radiant heat)?
Detailed Description
Thermoregulation is a major problem for low birth weight infants. The EPICure study showed that 36% of infants born between 24 and 25 weeks gestation had an admission temperature less than 35 degrees Celsius. Hypothermia is associated with increased risk of morbidity and mortality. The HeLP trial hopes to address these issues with the use of a polyethylene occlusive wrap applied immediately after delivery to infants born at less that 28 weeks gestation. Forty-five centers are currently involved in this study. Infant enrollments began in December 2004. Primary outcome: To determine if polyethylene occlusive wrap applied immediately after delivery to infants born between 24+0 and 27+6 weeks gestation results in decreased mortality compared with the conventional method of drying. Because of increased mortality and variable center specific resuscitation practices, infants born at less than 24 weeks gestation will be randomized as part of a separate Pilot Study and centers may choose if they wish to participate in this group or not. Secondary outcome: The key secondary outcome will be axillary temperature taken on introduction into a warm environment in the NICU. We will also record clinically important variables including: acidosis, hypotension, hypoglycaemia, seizures, patent ductus arteriosus, respiratory distress syndrome/chronic lung disease, necrotizing enterocolitis and head ultrasound results. Length of stay and cause of death at discharge will also be recorded. Long-term follow-up is critical to our understanding of the implications of any new intervention. As such, we ask parents from hospitals who agree to participate in the follow-up study for permission to contact them approximately 18 months after birth. Preterm infants meeting the eligibility criteria will be randomly assigned within three gestational age strata (less than 24 weeks, 24+0 to 25+6 weeks gestation, and 26+0 to 27+6 weeks gestation) to either the occlusive skin wrap group or the standard of care (non-wrap) group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypothermia in Premature Infants
Keywords
Hypothermia, premature infants, Polyethylene occlusive wrap

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
804 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Polyethylene occlusive skin wrap applied immediately after birth and removed after the infant has been admitted to a stable thermoneutral environment
Arm Title
2
Arm Type
No Intervention
Arm Description
Standard care
Intervention Type
Device
Intervention Name(s)
Polyethylene occlusive skin wrap
Other Intervention Name(s)
occlusive skin wrap
Intervention Description
Polyethylene occlusive skin wrap applied immediately after birth and removed after the infant has been admitted to a stable thermoneutral environment
Primary Outcome Measure Information:
Title
Death to discharge or at six months corrected gestational age
Time Frame
discharge or six months corrected gestational age
Secondary Outcome Measure Information:
Title
1. Axillary temperature upon arrival in Neonatal Intensive Care Unit (NICU)
Time Frame
upon arrival in NICU
Title
acidosis, hypotension, hypoglycaemia, seizures
Time Frame
first 12 hours of life
Title
4. Death and neurosensory disability measured at 18 months corrected gestational age
Time Frame
18 months corrected gestational age
Title
PDA, RDS, CLD, pneumothorax, sepsis, IVH, PVL, NEC, GI perforation, pulmonary hemorrhage, hearing, ROP
Time Frame
discharge from hospital or 6 months corrected gestational age

10. Eligibility

Sex
All
Minimum Age & Unit of Time
24 Weeks
Maximum Age & Unit of Time
28 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:Infants born at less than 28 weeks and who have prior to birth a firm decision to provide full resuscitative measures and intensive support. - Exclusion Criteria:1. Infants born with major congenital anomalies that are not covered by skin (e.g. gastroschisis, meningomyelocele) 2. Infants born with blistering skin conditions that preclude the use of occlusive wrap -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maureen C Reilly, RRT
Organizational Affiliation
Sunnybrook Health Sciences Centre
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sunita Vohra, MD FRCPC MSc
Organizational Affiliation
University of Alberta/Stollery Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
25449224
Citation
Reilly MC, Vohra S, Rac VE, Dunn M, Ferrelli K, Kiss A, Vincer M, Wimmer J, Zayack D, Soll RF; Vermont Oxford Network Heat Loss Prevention (HeLP) Trial Study Group. Randomized trial of occlusive wrap for heat loss prevention in preterm infants. J Pediatr. 2015 Feb;166(2):262-8.e2. doi: 10.1016/j.jpeds.2014.09.068. Epub 2014 Nov 12.
Results Reference
derived
PubMed Identifier
23770234
Citation
Vohra S, Reilly M, Rac VE, Bhaloo Z, Zayack D, Wimmer J, Vincer M, Ferrelli K, Kiss A, Soll R, Dunn M. Study protocol for multicentre randomized controlled trial of HeLP (Heat Loss Prevention) in the delivery room. Contemp Clin Trials. 2013 Sep;36(1):54-60. doi: 10.1016/j.cct.2013.06.001. Epub 2013 Jun 11.
Results Reference
derived
Links:
URL
http://www.vtoxford.org
Description
The Vermont Oxford Network

Learn more about this trial

Multicentre Randomised Controlled Trial of HELP (Heat Loss Prevention) in the Delivery Room

We'll reach out to this number within 24 hrs